Valerie Montgomery Rice to Female
This is a "connection" page, showing publications Valerie Montgomery Rice has written about Female.
Connection Strength
0.227
-
Montgomery Rice V. Diversity in Medical Schools: A Much-Needed New Beginning. JAMA. 2021 Jan 05; 325(1):23-24.
Score: 0.049
-
Kaunitz AM, Miller PD, Rice VM, Ross D, McClung MR. Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation. Contraception. 2006 Aug; 74(2):90-9.
Score: 0.018
-
Rice VM. Strategies and issues for managing menopause-related symptoms in diverse populations: ethnic and racial diversity. Am J Med. 2005 Dec 19; 118 Suppl 12B:142-7.
Score: 0.017
-
Rice VM. Post menopausal hormone therapy today. Ethn Dis. 2005; 15(2 Suppl 2):S34-9.
Score: 0.016
-
Rice VM. Effect of moderate-intensity exercise in alleviating menopausal symptoms. Menopause. 2004 Jul-Aug; 11(4):372-4.
Score: 0.015
-
Rice VM. Optimizing the dose of hormone replacement therapy. Int J Fertil Womens Med. 2002 Sep-Oct; 47(5):205-10.
Score: 0.014
-
Rice VM. Conventional medical therapies for endometriosis. Ann N Y Acad Sci. 2002 Mar; 955:343-52; discussion 389-93, 396-406.
Score: 0.013
-
Montgomery Rice V. Hormone replacement therapy: optimising the dose and route of administration. Drugs Aging. 2002; 19(11):807-18.
Score: 0.013
-
Carson SA, Eschenbach DA, Lomax G, Rice VM, Sauer MV, Taylor RN. Proposed oocyte donation guidelines for stem cell research. Fertil Steril. 2010 Dec; 94(7):2503-6.
Score: 0.011
-
Rida P, Ogden A, Ellis IO, Varga Z, Wolff AC, Traina TA, Hatzis C, Palmer JR, Ambrosone CB, Lehmann BD, Nanda R, Montgomery Rice V, Brawley OW, Torres MA, Rakha E, Aneja R. First international TNBC conference meeting report. Breast Cancer Res Treat. 2018 Jun; 169(3):407-412.
Score: 0.010
-
Son DS, Parl AK, Rice VM, Khabele D. Keratinocyte chemoattractant (KC)/human growth-regulated oncogene (GRO) chemokines and pro-inflammatory chemokine networks in mouse and human ovarian epithelial cancer cells. Cancer Biol Ther. 2007 Aug; 6(8):1302-12.
Score: 0.009
-
Bigby JA, Caine VA, Rice VM. Plenary session 2: Improving quality. Making a difference at the individual, business, and community levels. Ethn Dis. 2005; 15(2 Suppl 2):S68-73.
Score: 0.008
-
Zhang D, Al-Hendy M, Richard-Davis G, Montgomery-Rice V, Sharan C, Rajaratnam V, Khurana A, Al-Hendy A. Green tea extract inhibits proliferation of uterine leiomyoma cells in vitro and in nude mice. Am J Obstet Gynecol. 2010 Mar; 202(3):289.e1-9.
Score: 0.006
-
Zhang D, Al-Hendy M, Richard-Davis G, Montgomery-Rice V, Rajaratnam V, Al-Hendy A. Antiproliferative and proapoptotic effects of epigallocatechin gallate on human leiomyoma cells. Fertil Steril. 2010 Oct; 94(5):1887-93.
Score: 0.006
-
Khabele D, Son DS, Parl AK, Goldberg GL, Augenlicht LH, Mariadason JM, Rice VM. Drug-induced inactivation or gene silencing of class I histone deacetylases suppresses ovarian cancer cell growth: implications for therapy. Cancer Biol Ther. 2007 May; 6(5):795-801.
Score: 0.005
-
Curran EM, Tassell AH, Judy BM, Nowicki B, Montgomery-Rice V, Estes DM, Nowicki S. Estrogen increases menopausal host susceptibility to experimental ascending urinary-tract infection. J Infect Dis. 2007 Mar 01; 195(5):680-3.
Score: 0.005
-
Lobo RA, B?lisle S, Creasman WT, Frankel NR, Goodman NE, Hall JE, Ivey SL, Kingsberg S, Langer R, Lehman R, McArthur DB, Montgomery-Rice V, Notelovitz M, Packin GS, Rebar RW, Rousseau M, Schenken RS, Schneider DL, Sherif K, Wysocki S. Should symptomatic menopausal women be offered hormone therapy? MedGenMed. 2006; 8(2):1 p preceding 35.
Score: 0.004
-
Lobo RA, B?lisle S, Creasman WT, Frankel NR, Goodman NF, Hall JE, Ivey SL, Kingsberg S, Langer R, Lehman R, McArthur DB, Montgomery-Rice V, Notelovitz M, Packin GS, Rebar RW, Rousseau M, Schenken RS, Schneider DL, Sherif K, Wysocki S. Should symptomatic menopausal women be offered hormone therapy? MedGenMed. 2006; 8(3):40.
Score: 0.004
-
Roby KF, Son DS, Taylor CC, Montgomery-Rice V, Kirchoff J, Tang S, Terranova PF. Alterations in reproductive function in SRC tyrosine kinase knockout mice. Endocrine. 2005 Mar; 26(2):169-76.
Score: 0.004